Video

More Research is Needed to Prevent Late-Stage Diagnosis of Ovarian Cancer

A gynecologic-oncology clinical nurse specialist and one of this year’s CURE Ovarian Cancer Heroes discussed the lack of resources for patients with ovarian cancer and the need for more research.

Of the many challenges facing patients with ovarian cancer, one of the biggest is late-stage or delayed diagnosis due to the disease’s subtle signs and symptoms, according to Paula Anastasia RN, MN, AOCN.

At CURE’s Ovarian Cancer Heroes event, Anastasia — one of this year’s winners who works at the David Geffen School of Medicine at UCLA – discussed some of the resources that are lacking for patients with ovarian cancer.

“It is unfortunately one of the most fatal (forms of cancer) because it is diagnosed in the late stages,” said Anastasia, who has been a gynecologic-oncology clinical nurse specialist for more than 25 years. “The reason is there is not enough information on the signs and symptoms.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
Image of valarie with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Related Content